In a study by Gan et al., the expression of BRCA1 and PARP1 (in its intact and cleaved (C-PARP1) forms) was immunohistochemically semiquantified in 174 sporadic high-grade serous carcinoma patients. Here, BRCA1 is linked to serous adenocarcinoma.